Novartis AG
LSE:0QLR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
LSE:0QLR
|
CH |
|
W
|
Warner Bros Discovery Inc
XBER:J5A
|
US |
|
P
|
Primo Water Corp
F:GC6
|
US |
|
M
|
MFE-MEDIAFOREUROPE NV
F:T0J0
|
IT |
|
J
|
JFE Holdings Inc
DUS:JFR
|
JP |
|
Orca Gold Inc
XTSX:ORG
|
CA |
|
T
|
TryHard Holdings Ltd
NASDAQ:THH
|
JP |
|
Soitec SA
F:SOH1
|
FR |
|
A
|
ACS Actividades de Construccion y Servicios SA
DUS:OCI1
|
ES |
|
L
|
Life Healthcare Group Holdings Ltd
XBER:L53
|
ZA |
|
V
|
Vulcan Materials Co
DUS:VMC
|
US |
|
C
|
CVB Financial Corp
F:BCV
|
US |
Wall St Price Targets
0QLR Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for 0QLR is 123.65 CHF with a low forecast of 94.71 CHF and a high forecast of 145.1 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QLR's stock price target?
Price Target
123.65
CHF
According to Wall Street analysts, the average 1-year price target for 0QLR is 123.65 CHF with a low forecast of 94.71 CHF and a high forecast of 145.1 CHF.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
